Atopic dermatitis is associated with the clinical course of inflammatory bowel disease

References

• Sairenji T, Collins KL, Evans DV. An update on inflammatory bowel disease. Prim Care. 2017;44(4):673–692.
   PubMed Web of Science ®Google Scholar
• Nishida A, Inoue R, Inatomi O, et al. Gut microbiota in the pathogenesis of inflammatory bowel disease. Clin J Gastroenterol. 2018;11(1):1–10.
   PubMed Web of Science ®Google Scholar
• Monstad I, Hovde O, Solberg IC, et al. Clinical course and prognosis in ulcerative colitis: results from population-based and observational studies. Ann Gastroenterol. 2014;27:95–104.
   PubMedGoogle Scholar
• Shen B. Interventional IBD: the role of endoscopist in the multidisciplinary team management of IBD. Inflamm Bowel Dis. 2018;24(2):298–309.
   PubMed Web of Science ®Google Scholar
• Holdam AS, Bager P, Dahlerup JF. Biological therapy increases the health-related quality of life in patients with inflammatory bowel disease in a clinical setting. Scand J Gastroenterol. 2016;51(6):706–711.
   PubMed Web of Science ®Google Scholar
• Bieber T. Atopic dermatitis. N Engl J Med. 2008;358(14):1483–1494.
   PubMed Web of Science ®Google Scholar
• Gittler JK, Shemer A, Suarez-Farinas M, et al. Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis. J Allergy Clin Immunol. 2012;130(6):1344–1354.
   PubMed Web of Science ®Google Scholar
• Williams HC. Clinical practice. Atopic dermatitis. N Engl J Med. 2005;352(22):2314–2324.
   PubMed Web of Science ®Google Scholar
• Odhiambo JA, Williams HC, Clayton TO, et al. Global variations in prevalence of eczema symptoms in children from ISAAC phase three. J Allergy Clin Immunol. 2009;124(6):1251–1258 e23.
   PubMed Web of Science ®Google Scholar
• Silverberg JI, Hanifin JM. Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study. J Allergy Clin Immunol. 2013;132(5):1132–1138.
   PubMed Web of Science ®Google Scholar
• Berg DR, Colombel JF, Ungaro R. The role of early biologic therapy in inflammatory bowel disease. Inflamm Bowel Dis. 2019;25(12):1896–1905.
   PubMed Web of Science ®Google Scholar
• Kuenzig ME, Bishay K, Leigh R, et al. Co-occurrence of asthma and the inflammatory bowel diseases: a systematic review and meta-analysis. Clin Transl Gastroenterol. 2018;9:188.
   PubMed Web of Science ®Google Scholar
• Lee H, Lee JH, Koh SJ, et al. Bidirectional relationship between atopic dermatitis and inflammatory bowel disease: a systematic review and meta-analysis. J Am Acad Dermatol. 2020;83(5):1385–1394.
   PubMed Web of Science ®Google Scholar
• Darlenski R, Kazandjieva J, Hristakieva E, et al. Atopic dermatitis as a systemic disease. Clin Dermatol. 2014;32(3):409–413.
   PubMed Web of Science ®Google Scholar
• Soh H, Lee HJ, Han K, et al. Atopic diseases are associated with development of inflammatory bowel diseases in Korea: a nationwide population-based study. Clin Gastroenterol Hepatol. 2021;19(10):2072–2081 e6.
   PubMed Web of Science ®Google Scholar
• Shi X, Chen Q, Wang F. The bidirectional association between inflammatory bowel disease and atopic dermatitis: a systematic review and Meta-Analysis. Dermatology. 2020;236(6):546–553.
   PubMed Web of Science ®Google Scholar
• Weng YC, Juan CK, Ho HJ, et al. Atopic dermatitis does not increase the risk of inflammatory bowel disease: a nationwide cohort study. J Dermatol. 2021;48(2):168–174.
   PubMed Web of Science ®Google Scholar
• Schmitt J, Schwarz K, Baurecht H, et al. Atopic dermatitis is associated with an increased risk for rheumatoid arthritis and inflammatory bowel disease, and a decreased risk for type 1 diabetes. J Allergy Clin Immunol. 2016;137(1):130–136.
   PubMed Web of Science ®Google Scholar
• Matsuo K, Hatanaka S, Kimura Y, et al. A CCR4 antagonist ameliorates atopic dermatitis-like skin lesions induced by dibutyl phthalate and a hydrogel patch containing ovalbumin. Biomed Pharmacother. 2019;109:1437–1444.
   PubMed Web of Science ®Google Scholar
• Gwela A, Siddhanathi P, Chapman RW, et al. Th1 and innate lymphoid cells accumulate in primary sclerosing cholangitis-associated inflammatory bowel disease. J Crohns Colitis. 2017;11(9):1124–1134.
   PubMed Web of Science ®Google Scholar
• Heiseke AF, Faul AC, Lehr HA, et al. CCL17 promotes intestinal inflammation in mice and counteracts regulatory T cell-mediated protection from colitis. Gastroenterology. 2012;142(2):335–345.
   PubMed Web of Science ®Google Scholar
• Stutte S, Quast T, Gerbitzki N, et al. Requirement of CCL17 for CCR7- and CXCR4-dependent migration of cutaneous dendritic cells. Proc Natl Acad Sci USA. 2010;107(19):8736–8741.
   PubMed Web of Science ®Google Scholar
• Simpson EL, Papp KA, Blauvelt A, et al. Efficacy and safety of upadacitinib in patients with moderate to severe atopic dermatitis: analysis of follow-up data from the measure up 1 and measure up 2 randomized clinical trials. JAMA Dermatol. 2022;158(4):404–413.
   PubMed Web of Science ®Google Scholar
• Danese S, Vermeire S, Zhou W, et al. Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials. Lancet. 2022;399(10341):2113–2128.
   PubMed Web of Science ®Google Scholar
• Sugaya M. The role of Th17-Related cytokines in atopic dermatitis. Int J Mol Sci. 2020;21(4):1314.
   PubMed Web of Science ®Google Scholar
• Ellis SR, Nguyen M, Vaughn AR, et al. The skin and gut microbiome and its role in common dermatologic conditions. Microorganisms. 2019;7(11):550.
   PubMed Web of Science ®Google Scholar
• Ueno A, Jeffery L, Kobayashi T, et al. Th17 plasticity and its relevance to inflammatory bowel disease. J Autoimmun. 2018;87:38–49.
   PubMed Web of Science ®Google Scholar
• Schmidt-Weber CB, Akdis M, Akdis CA. TH17 cells in the big picture of immunology. J Allergy Clin Immunol. 2007;120(2):247–254.
   PubMed Web of Science ®Google Scholar
• Koga C, Kabashima K, Shiraishi N, et al. Possible pathogenic role of Th17 cells for atopic dermatitis. J Invest Dermatol. 2008;128(11):2625–2630.
   PubMed Web of Science ®Google Scholar
• Brand S. Crohn’s disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn’s disease. Gut. 2009;58(8):1152–1167.
   PubMed Web of Science ®Google Scholar
• Vitaliti G, Pavone P, Guglielmo F, et al. The immunomodulatory effect of probiotics beyond atopy: an update. J Asthma. 2014;51(3):320–332.
   PubMed Web of Science ®Google Scholar
• Honda K, Littman DR. The microbiome in infectious disease and inflammation. Annu Rev Immunol. 2012;30:759–795.
   PubMed Web of Science ®Google Scholar
• Werfel T, Allam JP, Biedermann T, et al. Cellular and molecular immunologic mechanisms in patients with atopic dermatitis. J Allergy Clin Immunol. 2016;138(2):336–349.
   PubMed Web of Science ®Google Scholar